From the moment he entered the world, little Toby’s life was marked by uncertainty. Before his birth, doctors had spotted a mysterious mass on his tiny arm. Early tests offered reassurance—perhaps it was nothing serious. But within weeks, that hope was shattered. The mass wasn’t harmless. It was cancer.
For Toby’s parents, Jenaya and Josh, the diagnosis brought a flood of fear and impossible decisions. At only three months old, their baby boy was nearly scheduled for an amputation in a desperate attempt to save his life. But at the last moment, doctors decided to try a stronger round of chemotherapy instead. It was a risky choice, one that came with no guarantees.
And then, something extraordinary happened.
The tumor stopped growing.
What followed was a grueling stretch of hospital stays, sleepless nights, and countless blood transfusions. Toby endured more in his first year of life than many people face in a lifetime. Yet through every setback, his family clung to hope—hope that their son’s story wasn’t finished yet.
That hope finally took shape in the form of a targeted medication called crizotinib. Unlike standard chemotherapy, this treatment was designed specifically to attack the type of cancer Toby was fighting. Slowly, miraculously, the tumor began to shrink.
Today, Toby is learning to smile, play, and reach for the world around him. He laughs at his parents’ faces, grips toys with surprising strength, and discovers joy in the simplest moments—tiny victories that once felt out of reach.
But the journey isn’t over. Each scan brings new questions. Each day is another step into the unknown. Still, Toby’s resilience continues to inspire everyone who meets him.
His story is a testament to fear, love, medical innovation—and the incredible courage of one very small, very strong child.